FY2025 · ended Dec 31, 2025 · Revenue $89.06M, +36.1% YoY · Filed Feb 24, 2026
CeriBell, Inc. (CBLL) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $89.1 million and a net loss of $53.4 million. Free cash flow was -$41.6 million. As of Sep 30, 2026 it held $117.5 million in cash and investments and $1.6 million in total debt.
Revenue (TTM)
$108.72M
+31.3% vs year-ago TTM
Net income (TTM)
$-73.88M
-40.8% vs year-ago TTM
Operating cash flow (TTM)
$-56.01M
-40.0% vs year-ago TTM
Free cash flow (TTM)
$-56.43M
-37.8% vs year-ago TTM
EPS (TTM)
$-1.95
-30.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
37.64M
+4.9% vs prior year
Net cash
$115.82M
as of Sep 30, 2026
Operating margin
-69.8%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CBLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1861107
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
|---|---|---|
| Revenue | $89.1M | $65.4M |
| Operating income | -$58.4M | -$39.7M |
| Net income | -$53.4M | -$40.5M |
| Diluted EPS | -$1.46 | -$3.39 |
| Operating cash flow | -$40.8M | -$35.0M |
| Free cash flow | -$41.6M | -$36.4M |
| Total assets | $195.8M | $225.4M |
| Total liabilities | $40.5M | $34.2M |
| Stockholders' equity | $155.3M | $191.2M |
| Cash and investments | $159.3M | $194.4M |
| Total debt | $2.5M | $2.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | Jun 2, 2026 |
All 306 CeriBell, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.